RLMD vs MSFT: Which Stock is Better?

Side-by-side comparison of Relmada Therapeutics Inc and Microsoft Corporation in 2026

Comparison Updated:

RLMD

Relmada Therapeutics Inc

$4.50

MSFT

Microsoft Corporation

$499.32

Key Metrics Comparison

MetricRLMDMSFTWinner
Market Cap$692.28M$3.71TMSFT
P/E RatioN/A33.89MSFT
EPS (TTM)$N/A$14.08MSFT
Revenue Growth0.0%18.4%MSFT
Gross Margin0.0%67.9%MSFT

Analyze RLMD

Full quant analysis

Analyze MSFT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is RLMD or MSFT a better investment?

Comparing RLMD and MSFT: Relmada Therapeutics Inc has a market cap of $692.28M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between RLMD and MSFT?

RLMD (Relmada Therapeutics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: RLMD or MSFT?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: RLMD or MSFT?

MSFT has higher revenue growth at 18.4% vs 0.0% for RLMD.

Which company is more profitable: RLMD or MSFT?

Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for RLMD.

Which is the larger company: RLMD or MSFT?

Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $692.28M for RLMD.

Should I buy RLMD or MSFT in 2026?

Both RLMD and MSFT have investment merit. RLMD trades at $4.50 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between RLMD and MSFT stock?

Key differences: Market Cap ($692.28M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).

Should I buy RLMD or MSFT in 2026?

The choice between RLMD and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.

What is the market cap comparison between RLMD and MSFT?

RLMD (Relmada Therapeutics Inc) has a market cap of $692.28M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.

Popular Stock Comparisons